BioCentury
ARTICLE | Clinical News

TPI ASM8: Phase II started

March 12, 2007 7:00 AM UTC

Topigen started a placebo-controlled, double-blind, Canadian Phase II trial in 60 patients who will receive either 250 or 500 µg of inhaled TPI ASM8 or placebo. ...